COSCIENS Biopharma Inc. CSCI.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · cosciensbio.com
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris) is a Canadian life science company that develops and commercializes natural, plant-based active ingredients derived from oats and pharmaceutical products through its subsidiary Ceapro. The company serves the cosmeceutical, nutraceutical, and pharmaceutical markets and also markets Macrilen (macimorelin), an orally active growth hormone stimulator. COSCIENS is headquartered in Edmonton, Alberta.
Key ratios
FreeCashFlowOnSale TTM -1.22
FreeCashFlowOnSale 2025 -1.22
FreeCashFlowOnSale 2024 -1.64
FreeCashFlowOnSale 2023 -0.46
NetIncomeMargin TTM -1.38
NetIncomeMargin 2025 -1.38
NetIncomeMargin 2024 -1.6
NetIncomeMargin 2023 -0.49
ReturnOnAssets TTM -0.23
ReturnOnAssets 2025 -0.23
ReturnOnAssets 2024 -0.21
ReturnOnAssets 2023 -0.07
ReturnOnEquity TTM -1.22
ReturnOnEquity 2025 -1.22
ReturnOnEquity 2024 -0.9
ReturnOnEquity 2023 -0.12
Recent news
COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment
2026-06-23 · GlobeNewswire